| Symbol |
Name |
Standardized Value |
|
TG
|
thyroglobulin
|
3.783
|
|
TPO
|
thyroid peroxidase
|
3.451
|
|
TSHR
|
thyroid stimulating hormone receptor
|
3.042
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
3.026
|
|
CD274
|
CD274 molecule
|
2.81
|
|
PDCD1
|
programmed cell death 1
|
2.772
|
|
CD4
|
CD4 molecule
|
2.739
|
|
CD8A
|
CD8a molecule
|
2.616
|
|
FOXP3
|
forkhead box P3
|
2.542
|
|
CRP
|
C-reactive protein, pentraxin-related
|
2.533
|
|
IFNG
|
interferon, gamma
|
2.512
|
|
IFNA1
|
interferon, alpha 1
|
2.492
|
|
IL2
|
interleukin 2
|
2.471
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
2.425
|
|
ATP5PO
|
ATP synthase peripheral stalk subunit OSCP
|
2.416
|
|
POMC
|
proopiomelanocortin
|
2.403
|
|
IL6
|
interleukin 6
|
2.397
|
|
PRSS3
|
protease, serine, 3
|
2.386
|
|
SERPINA7
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7
|
2.344
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
2.334
|
|
TNF
|
tumor necrosis factor
|
2.313
|
|
CD28
|
CD28 molecule
|
2.303
|
|
IL10
|
interleukin 10
|
2.299
|
|
ACE2
|
angiotensin I converting enzyme 2
|
2.288
|
|
PXDNL
|
peroxidasin-like
|
2.274
|
|
PXDN
|
peroxidasin
|
2.273
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
2.269
|
|
IFNA2
|
interferon, alpha 2
|
2.264
|
|
IL17A
|
interleukin 17A
|
2.248
|
|
INS
|
insulin
|
2.235
|
|
CD80
|
CD80 molecule
|
2.235
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
2.234
|
|
TRH
|
thyrotropin-releasing hormone
|
2.227
|
|
AIRE
|
autoimmune regulator
|
2.226
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
2.211
|
|
RET
|
ret proto-oncogene
|
2.201
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
2.191
|
|
IFNA17
|
interferon, alpha 17
|
2.183
|
|
IFNA7
|
interferon, alpha 7
|
2.176
|
|
IFNA8
|
interferon, alpha 8
|
2.175
|
|
IFNA10
|
interferon, alpha 10
|
2.174
|
|
IFNA6
|
interferon, alpha 6
|
2.173
|
|
IFNA21
|
interferon, alpha 21
|
2.172
|
|
IFNA16
|
interferon, alpha 16
|
2.172
|
|
IFNA5
|
interferon, alpha 5
|
2.171
|
|
IFNA14
|
interferon, alpha 14
|
2.171
|
|
IFNA4
|
interferon, alpha 4
|
2.171
|
|
IFNA13
|
interferon, alpha 13
|
2.169
|
|
IL4
|
interleukin 4
|
2.167
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
2.161
|
|
IL1B
|
interleukin 1, beta
|
2.156
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
2.141
|
|
CD86
|
CD86 molecule
|
2.126
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
2.108
|
|
PTH
|
parathyroid hormone
|
2.101
|
|
PRL
|
prolactin
|
2.094
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
2.092
|
|
TGFB1
|
transforming growth factor, beta 1
|
2.067
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
2.052
|
|
SLC30A10
|
solute carrier family 30, member 10
|
2.049
|
|
ALB
|
albumin
|
2.034
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
2.027
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
2.013
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
2.009
|
|
LAG3
|
lymphocyte-activation gene 3
|
1.996
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
1.985
|
|
CD19
|
CD19 molecule
|
1.979
|
|
NUDT10
|
nudix (nucleoside diphosphate linked moiety X)-type motif 10
|
1.948
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
1.942
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
1.935
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.927
|
|
FOXE1
|
forkhead box E1
|
1.925
|
|
ICOS
|
inducible T-cell co-stimulator
|
1.918
|
|
IL1A
|
interleukin 1, alpha
|
1.914
|
|
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18
|
1.904
|
|
CD40LG
|
CD40 ligand
|
1.903
|
|
PAX8
|
paired box 8
|
1.899
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
1.898
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
1.884
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
1.882
|
|
TRIM21
|
tripartite motif containing 21
|
1.86
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.843
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
1.827
|
|
CD27
|
CD27 molecule
|
1.827
|
|
ACE
|
angiotensin I converting enzyme
|
1.824
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
1.817
|
|
LRBA
|
LPS-responsive vesicle trafficking, beach and anchor containing
|
1.816
|
|
IL5
|
interleukin 5
|
1.807
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
1.807
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
1.797
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
1.788
|
|
IL13
|
interleukin 13
|
1.78
|
|
CD52
|
CD52 molecule
|
1.776
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
1.765
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
1.762
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
1.756
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
1.75
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
1.748
|
|
CD276
|
CD276 molecule
|
1.747
|
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter)
|
1.743
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.743
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
1.737
|
|
NKX2-1
|
NK2 homeobox 1
|
1.736
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.736
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
1.735
|
|
TGM2
|
transglutaminase 2
|
1.735
|
|
IL7R
|
interleukin 7 receptor
|
1.731
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.731
|
|
PRF1
|
perforin 1 (pore forming protein)
|
1.719
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
1.717
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
1.701
|
|
PRTN3
|
proteinase 3
|
1.699
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
1.697
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1.691
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
1.688
|
|
CD68
|
CD68 molecule
|
1.687
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
1.687
|
|
MUSK
|
muscle, skeletal, receptor tyrosine kinase
|
1.682
|
|
IL15
|
interleukin 15
|
1.676
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.669
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
1.665
|
|
NCOA4
|
nuclear receptor coactivator 4
|
1.662
|
|
IL22
|
interleukin 22
|
1.662
|
|
IL7
|
interleukin 7
|
1.655
|
|
CD5
|
CD5 molecule
|
1.65
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
1.648
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
1.643
|
|
SELL
|
selectin L
|
1.642
|
|
TIGIT
|
T cell immunoreceptor with Ig and ITIM domains
|
1.642
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
1.625
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.621
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
1.618
|
|
CRH
|
corticotropin releasing hormone
|
1.616
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.611
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
1.611
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
1.602
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.6
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.594
|
|
TP53
|
tumor protein p53
|
1.591
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.581
|
|
PMEL
|
premelanosome protein
|
1.58
|
|
TBX21
|
T-box 21
|
1.576
|
|
EGFR
|
epidermal growth factor receptor
|
1.571
|
|
REN
|
renin
|
1.566
|
|
THRB
|
thyroid hormone receptor, beta
|
1.563
|
|
TERT
|
telomerase reverse transcriptase
|
1.561
|
|
IL18
|
interleukin 18
|
1.559
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.559
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.555
|
|
KRT19
|
keratin 19, type I
|
1.554
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.554
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
1.553
|
|
PTCH1
|
patched 1
|
1.551
|
|
GNAL
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type
|
1.55
|
|
CD38
|
CD38 molecule
|
1.549
|
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
1.548
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
1.547
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
1.543
|
|
ICAM1
|
intercellular adhesion molecule 1
|
1.542
|
|
F2
|
coagulation factor II (thrombin)
|
1.541
|
|
CKB
|
creatine kinase, brain
|
1.54
|
|
CKM
|
creatine kinase, muscle
|
1.539
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
1.536
|
|
CD34
|
CD34 molecule
|
1.534
|
|
SST
|
somatostatin
|
1.529
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
1.519
|
|
TLR4
|
toll-like receptor 4
|
1.519
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
1.515
|
|
CD69
|
CD69 molecule
|
1.513
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
1.502
|
|
COL17A1
|
collagen, type XVII, alpha 1
|
1.5
|
|
TLR9
|
toll-like receptor 9
|
1.494
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
1.494
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
1.489
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
1.488
|
|
RAG1
|
recombination activating gene 1
|
1.487
|
|
GPT2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
1.486
|
|
MBP
|
myelin basic protein
|
1.484
|
|
SLC44A4
|
solute carrier family 44, member 4
|
1.484
|
|
BTLA
|
B and T lymphocyte associated
|
1.481
|
|
TXNRD2
|
thioredoxin reductase 2
|
1.472
|
|
AMPH
|
amphiphysin
|
1.468
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.464
|
|
TPCN1
|
two pore segment channel 1
|
1.464
|
|
TLR7
|
toll-like receptor 7
|
1.461
|
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
1.455
|
|
LEP
|
leptin
|
1.442
|
|
SDC1
|
syndecan 1
|
1.442
|
|
TLR2
|
toll-like receptor 2
|
1.441
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
1.437
|
|
FAS
|
Fas cell surface death receptor
|
1.436
|
|
MPO
|
myeloperoxidase
|
1.434
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.429
|
|
FCRL3
|
Fc receptor-like 3
|
1.428
|
|
IDO2
|
indoleamine 2,3-dioxygenase 2
|
1.426
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
1.423
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
1.422
|
|
PTEN
|
phosphatase and tensin homolog
|
1.42
|
|
GATA3
|
GATA binding protein 3
|
1.41
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
1.409
|
|
H2AC21
|
H2A clustered histone 21
|
1.409
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
1.408
|
|
LOC102723407
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
1.407
|
|
NTAN1
|
N-terminal asparagine amidase
|
1.406
|
|
CLTA
|
clathrin, light chain A
|
1.405
|
|
PPP1R3C
|
protein phosphatase 1, regulatory subunit 3C
|
1.4
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
1.398
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
1.392
|
|
TLR3
|
toll-like receptor 3
|
1.389
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
1.386
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
1.384
|
|
MME
|
membrane metallo-endopeptidase
|
1.381
|
|
CD163
|
CD163 molecule
|
1.38
|
|
IL9
|
interleukin 9
|
1.38
|
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2
|
1.372
|
|
H2BC21
|
H2B clustered histone 21
|
1.372
|
|
C6ORF15
|
chromosome 6 open reading frame 15
|
1.371
|
|
PPP1R3B
|
protein phosphatase 1, regulatory subunit 3B
|
1.37
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
1.367
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
1.366
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
1.365
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
1.362
|
|
EIF1AX
|
eukaryotic translation initiation factor 1A, X-linked
|
1.36
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
1.359
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
1.358
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
1.357
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
1.356
|
|
NPPB
|
natriuretic peptide B
|
1.356
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
1.355
|
|
IL2RB
|
interleukin 2 receptor, beta
|
1.353
|
|
AVP
|
arginine vasopressin
|
1.352
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
1.351
|
|
C3
|
complement component 3
|
1.35
|
|
BIN1
|
bridging integrator 1
|
1.348
|
|
LOC102723996
|
ICOS ligand
|
1.34
|
|
ITM2B
|
integral membrane protein 2B
|
1.339
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
1.33
|
|
CD1D
|
CD1d molecule
|
1.33
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
1.33
|
|
JAK2
|
Janus kinase 2
|
1.329
|
|
CCRL2
|
chemokine (C-C motif) receptor-like 2
|
1.328
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
1.327
|
|
JAK1
|
Janus kinase 1
|
1.323
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1.322
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
1.321
|
|
NLRP5
|
NLR family, pyrin domain containing 5
|
1.313
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
1.312
|
|
GCG
|
glucagon
|
1.31
|
|
SHBG
|
sex hormone-binding globulin
|
1.306
|
|
SLC16A10
|
solute carrier family 16 (aromatic amino acid transporter), member 10
|
1.302
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
1.3
|
|
MYD88
|
myeloid differentiation primary response 88
|
1.293
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
1.29
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
1.286
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
1.284
|
|
TSHB
|
thyroid stimulating hormone, beta
|
1.284
|
|
GPX3
|
glutathione peroxidase 3
|
1.281
|
|
CD81
|
CD81 molecule
|
1.28
|
|
ESR1
|
estrogen receptor 1
|
1.28
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
1.278
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
1.275
|
|
BCR
|
breakpoint cluster region
|
1.273
|
|
CD44
|
CD44 molecule (Indian blood group)
|
1.272
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
1.271
|
|
THRA
|
thyroid hormone receptor, alpha
|
1.271
|
|
SELENOS
|
selenoprotein S
|
1.268
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
1.266
|
|
DOCK8
|
dedicator of cytokinesis 8
|
1.264
|
|
VWF
|
von Willebrand factor
|
1.263
|
|
CHGA
|
chromogranin A
|
1.26
|
|
CTAG1B
|
cancer/testis antigen 1B
|
1.258
|
|
B2M
|
beta-2-microglobulin
|
1.257
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.256
|
|
CD1C
|
CD1c molecule
|
1.255
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
1.251
|
|
DST
|
dystonin
|
1.25
|
|
TTR
|
transthyretin
|
1.249
|
|
AMH
|
anti-Mullerian hormone
|
1.248
|
|
LGI1
|
leucine-rich, glioma inactivated 1
|
1.247
|
|
IL17F
|
interleukin 17F
|
1.247
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
1.247
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
1.246
|
|
SEPSECS
|
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase
|
1.246
|
|
SELENOP
|
selenoprotein P
|
1.242
|
|
CD226
|
CD226 molecule
|
1.241
|
|
STAT4
|
signal transducer and activator of transcription 4
|
1.238
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
1.238
|
|
PLA2R1
|
phospholipase A2 receptor 1, 180kDa
|
1.237
|
|
ENO1
|
enolase 1, (alpha)
|
1.234
|
|
CLEC16A
|
C-type lectin domain family 16, member A
|
1.232
|
|
CD2
|
CD2 molecule
|
1.212
|
|
H2AC20
|
H2A clustered histone 20
|
1.21
|
|
H2AC18
|
H2A clustered histone 18
|
1.209
|
|
HP
|
haptoglobin
|
1.208
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
1.206
|
|
CNTNAP2
|
contactin associated protein-like 2
|
1.204
|
|
VSIR
|
V-set immunoregulatory receptor
|
1.201
|
|
CASR
|
calcium-sensing receptor
|
1.2
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
1.198
|
|
ADA
|
adenosine deaminase
|
1.197
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
1.196
|
|
TYR
|
tyrosinase
|
1.196
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
1.194
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
1.194
|
|
FLNB
|
filamin B, beta
|
1.192
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
1.189
|
|
PDPN
|
podoplanin
|
1.189
|
|
IL21
|
interleukin 21
|
1.189
|
|
DIO1
|
deiodinase, iodothyronine, type I
|
1.188
|
|
IL23R
|
interleukin 23 receptor
|
1.188
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
1.187
|
|
CD22
|
CD22 molecule
|
1.185
|
|
NELFCD
|
negative elongation factor complex member C/D
|
1.179
|
|
RAG2
|
recombination activating gene 2
|
1.179
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
1.177
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
1.174
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
1.173
|
|
DPYSL5
|
dihydropyrimidinase-like 5
|
1.173
|
|
AFP
|
alpha-fetoprotein
|
1.167
|
|
CA2
|
carbonic anhydrase II
|
1.167
|
|
PNMA2
|
paraneoplastic Ma antigen 2
|
1.165
|
|
MB
|
myoglobin
|
1.159
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
1.158
|
|
C20ORF144
|
chromosome 20 open reading frame 144
|
1.156
|
|
IRF4
|
interferon regulatory factor 4
|
1.152
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
1.152
|
|
ACKR2
|
atypical chemokine receptor 2
|
1.15
|
|
RO60
|
Ro60, Y RNA binding protein
|
1.148
|
|
FLT1
|
fms-related tyrosine kinase 1
|
1.148
|
|
CD70
|
CD70 molecule
|
1.145
|
|
LTA
|
lymphotoxin alpha
|
1.144
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
1.14
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
1.139
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
1.138
|
|
LTF
|
lactotransferrin
|
1.137
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
1.136
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
1.135
|
|
SNRNP70
|
small nuclear ribonucleoprotein 70kDa (U1)
|
1.134
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
1.134
|
|
RNASET2
|
ribonuclease T2
|
1.133
|
|
GAST
|
gastrin
|
1.132
|
|
GPX8
|
glutathione peroxidase 8 (putative)
|
1.13
|
|
CD1A
|
CD1a molecule
|
1.129
|
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
|
1.128
|
|
ANXA11
|
annexin A11
|
1.128
|
|
GPX7
|
glutathione peroxidase 7
|
1.127
|
|
GPX2
|
glutathione peroxidase 2
|
1.126
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
1.126
|
|
PF4
|
platelet factor 4
|
1.125
|
|
IRF1
|
interferon regulatory factor 1
|
1.125
|
|
GPX6
|
glutathione peroxidase 6
|
1.123
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
1.123
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
1.123
|
|
CD1B
|
CD1b molecule
|
1.122
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
1.12
|
|
EGF
|
epidermal growth factor
|
1.12
|
|
DPP10
|
dipeptidyl-peptidase 10 (non-functional)
|
1.119
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
1.119
|
|
DPP4
|
dipeptidyl-peptidase 4
|
1.118
|
|
DNAL1
|
dynein, axonemal, light chain 1
|
1.117
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
1.116
|
|
DUOXA2
|
dual oxidase maturation factor 2
|
1.116
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
1.115
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
1.115
|
|
GPX5
|
glutathione peroxidase 5
|
1.113
|
|
CD1E
|
CD1e molecule
|
1.112
|
|
SLAMF7
|
SLAM family member 7
|
1.111
|
|
PVR
|
poliovirus receptor
|
1.111
|
|
IL1R1
|
interleukin 1 receptor, type I
|
1.111
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
1.11
|
|
SYP
|
synaptophysin
|
1.11
|
|
GH1
|
growth hormone 1
|
1.109
|
|
TPX2
|
TPX2, microtubule-associated
|
1.109
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
1.108
|
|
AICDA
|
activation-induced cytidine deaminase
|
1.105
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
1.105
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
1.104
|
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
1.102
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
1.1
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
1.1
|
|
THY1
|
Thy-1 cell surface antigen
|
1.1
|
|
CD58
|
CD58 molecule
|
1.1
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.099
|
|
KDR
|
kinase insert domain receptor
|
1.096
|
|
CD207
|
CD207 molecule, langerin
|
1.096
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
1.096
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
1.095
|
|
NRP1
|
neuropilin 1
|
1.095
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
1.094
|
|
SRP54
|
signal recognition particle 54kDa
|
1.093
|
|
DPP6
|
dipeptidyl-peptidase 6
|
1.091
|
|
ACTB
|
actin, beta
|
1.09
|
|
LTB
|
lymphotoxin beta (TNF superfamily, member 3)
|
1.09
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
1.085
|
|
JUN
|
jun proto-oncogene
|
1.085
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
1.082
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
1.082
|
|
KLRD1
|
killer cell lectin-like receptor subfamily D, member 1
|
1.08
|
|
TTC7A
|
tetratricopeptide repeat domain 7A
|
1.079
|
|
CD247
|
CD247 molecule
|
1.079
|
|
DUOX2
|
dual oxidase 2
|
1.078
|
|
RBM45
|
RNA binding motif protein 45
|
1.076
|
|
IL10RB
|
interleukin 10 receptor, beta
|
1.075
|
|
EOMES
|
eomesodermin
|
1.073
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
1.073
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
1.073
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
1.072
|
|
IL33
|
interleukin 33
|
1.07
|
|
KRT7
|
keratin 7, type II
|
1.07
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
1.068
|
|
LGALS9B
|
lectin, galactoside-binding, soluble, 9B
|
1.065
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
1.064
|
|
LGALS9C
|
lectin, galactoside-binding, soluble, 9C
|
1.063
|
|
DSG1
|
desmoglein 1
|
1.063
|
|
GZMH
|
granzyme H (cathepsin G-like 2, protein h-CCPX)
|
1.063
|
|
IKZF4
|
IKAROS family zinc finger 4 (Eos)
|
1.062
|
|
SH2B3
|
SH2B adaptor protein 3
|
1.062
|
|
TTN
|
titin
|
1.059
|
|
TLR8
|
toll-like receptor 8
|
1.058
|
|
MRO
|
maestro
|
1.058
|
|
MAGEA3
|
melanoma antigen family A3
|
1.058
|
|
SH2D1A
|
SH2 domain containing 1A
|
1.057
|
|
DSG3
|
desmoglein 3
|
1.056
|
|
IFNL1
|
interferon, lambda 1
|
1.056
|
|
DLAT
|
dihydrolipoamide S-acetyltransferase
|
1.056
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
1.053
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
1.047
|
|
CENPB
|
centromere protein B, 80kDa
|
1.045
|
|
THSD7A
|
thrombospondin, type I, domain containing 7A
|
1.045
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
1.043
|
|
TMIGD2
|
transmembrane and immunoglobulin domain containing 2
|
1.043
|
|
IL3
|
interleukin 3
|
1.042
|
|
TFRC
|
transferrin receptor
|
1.037
|
|
MUC1
|
mucin 1, cell surface associated
|
1.037
|
|
IL6R
|
interleukin 6 receptor
|
1.031
|
|
TSLP
|
thymic stromal lymphopoietin
|
1.03
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
1.029
|
|
CSH1
|
chorionic somatomammotropin hormone 1 (placental lactogen)
|
1.029
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
1.029
|
|
CSH2
|
chorionic somatomammotropin hormone 2
|
1.025
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
1.025
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
1.025
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
1.025
|
|
ECM1
|
extracellular matrix protein 1
|
1.025
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
1.024
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
1.024
|
|
GHRH
|
growth hormone releasing hormone
|
1.022
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
1.021
|
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex)
|
1.019
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
1.019
|
|
HMGB1
|
high mobility group box 1
|
1.018
|
|
GNLY
|
granulysin
|
1.017
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
1.015
|
|
KCNJ18
|
potassium channel, inwardly rectifying subfamily J, member 18
|
1.014
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
1.012
|
|
KRT27
|
keratin 27, type I
|
1.011
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
1.01
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
1.004
|
|
CALR
|
calreticulin
|
1.002
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
1.001
|
